Arthur F. Ryan - 03 Oct 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role: Director
Signature: /s/**Arthur F. Ryan
Issuer symbol: REGN
Transactions as of: 03 Oct 2022
Net transactions value: -$72,654
Form type: 4
Filing time: 05 Oct 2022, 16:10:09 UTC
Previous filing: 08 Sep 2022
Next filing: 03 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	REGN	Common Stock	Sale	$1,411	-2	-0.01%	$705.39	19,580	03 Oct 2022	Direct	F1
transaction	REGN	Common Stock	Sale	$2,132	-3	-0.02%	$710.73	19,577	03 Oct 2022	Direct	F1
transaction	REGN	Common Stock	Sale	$3,555	-5	-0.03%	$711.00	19,572	03 Oct 2022	Direct	F1
transaction	REGN	Common Stock	Sale	$1,428	-2	-0.01%	$714.08	19,570	03 Oct 2022	Direct	F1
transaction	REGN	Common Stock	Sale	$4,296	-6	-0.03%	$715.94	19,564	03 Oct 2022	Direct	F1, F2
transaction	REGN	Common Stock	Sale	$1,436	-2	-0.01%	$717.87	19,562	03 Oct 2022	Direct	F1
transaction	REGN	Common Stock	Sale	$2,155	-3	-0.02%	$718.48	19,559	03 Oct 2022	Direct	F1
transaction	REGN	Common Stock	Sale	$726	-1	-0.01%	$726.03	19,558	03 Oct 2022	Direct	F1
transaction	REGN	Common Stock	Sale	$13,095	-18	-0.09%	$727.52	19,540	03 Oct 2022	Direct	F1, F3
transaction	REGN	Common Stock	Sale	$13,836	-19	-0.1%	$728.23	19,521	03 Oct 2022	Direct	F1, F4
transaction	REGN	Common Stock	Sale	$1,460	-2	-0.01%	$730.00	19,519	03 Oct 2022	Direct	F1
transaction	REGN	Common Stock	Sale	$4,389	-6	-0.03%	$731.49	19,513	03 Oct 2022	Direct	F1, F5
transaction	REGN	Common Stock	Sale	$5,127	-7	-0.04%	$732.47	19,506	03 Oct 2022	Direct	F1, F6
transaction	REGN	Common Stock	Sale	$17,607	-24	-0.12%	$733.64	19,482	03 Oct 2022	Direct	F1, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2	Represents volume-weighted average price of sales of 6 shares of Company stock on October 3, 2022 at prices ranging from $715.91 to $715.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 3, 2022 at each separate price.
F3	Represents volume-weighted average price of sales of 18 shares of Company stock on October 3, 2022 at prices ranging from $727.48 to $727.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 3, 2022 at each separate price.
F4	Represents volume-weighted average price of sales of 19 shares of Company stock on October 3, 2022 at prices ranging from $728.03 to $728.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 3, 2022 at each separate price.
F5	Represents volume-weighted average price of sales of 6 shares of Company stock on October 3, 2022 at prices ranging from $731.43 to $731.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 3, 2022 at each separate price.
F6	Represents volume-weighted average price of sales of 7 shares of Company stock on October 3, 2022 at prices ranging from $732.00 to $732.65. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 3, 2022 at each separate price.
F7	Represents volume-weighted average price of sales of 24 shares of Company stock on October 3, 2022 at prices ranging from $733.12 to $733.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 3, 2022 at each separate price.